Evidence map›Paper›PMID 27859486›Full record

ReviewJournal of neuroscience research2017

Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Timothy P Rutkowski, Jason P Schroeder, Georgette M Gafford, Stephen T Warren, David Weinshenker, Tamara Caspary, Jennifer G Mulle

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroscience research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Mitochondrial Proteostasis Requires Genes Encoded in a Neurodevelopmental Syndrome Locus.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  7. Article
  8. Article
  9. Translational medicine of the glutamate AMPA receptor.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. eNeuro
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Timothy P RutkowskiDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Jason P SchroederDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Georgette M GaffordDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Stephen T WarrenDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Tamara CasparyDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Jennifer G MulleDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Emory University · US

Funding

Characterization of the Schizophrenia-associated 3q29 Deletion in MouseR01GM097331 · NIGMS · EMORY UNIVERSITY · PI CASPARY, TAMARA J., WARREN, STEPHEN T. · 2012 to 2015
$1.8M
NIGMS NIH HHS R01 GM097331
6 · The paper itself

Abstract

Recent studies show that the complex genetic architecture of schizophrenia (SZ) is driven in part by polygenic components, or the cumulative effect of variants of small effect in many genes, as well as rare single-locus variants with large effect sizes. Here we discuss genetic aberrations known as copy number variants (CNVs), which fall in the latter category and are associated with a high risk for SZ and other neuropsychiatric disorders. We briefly review recurrent CNVs associated with SZ, and then highlight one CNV in particular, a recurrent 1.6-Mb deletion on chromosome 3q29, which is estimated to confer a 40-fold increased risk for SZ. Additionally, we describe the use of genetic mouse models, behavioral tools, and patient-derived induced pluripotent stem cells as a means to study CNVs in the hope of gaining mechanistic insight into their respective disorders. Taken together, the genomic data connecting CNVs with a multitude of human neuropsychiatric disease, our current technical ability to model such chromosomal anomalies in mouse, and the existence of precise behavioral measures of endophenotypes argue that the time is ripe for systematic dissection of the genetic mechanisms underlying such disease. © 2016 Wiley Periodicals, Inc.

Indexed as

Genetic Predisposition to DiseaseAnimalsChromosome DeletionChromosomes, Human, Pair 3Developmental DisabilitiesDNA Copy Number VariationsHumansIntellectual DisabilitySchizophreniabehavioral assaysCNVsCRISPRgeneticsschizophrenia

Identifiers

PMID27859486
PMCPMC5352473
OpenAlexW2554197039

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.